Join the neffy group to help and get support from people like you.
neffy News
ARS Pharmaceuticals Announces FDA Approval of neffy 1 mg (epinephrine nasal spray) for Type I Allergic Reactions in Pediatric Patients
SAN DIEGO, March 05, 2025 (GLOBE NEWSWIRE) – ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect...
ACAAI: Many Anaphylaxis Protocols Are Incomplete, Outdated
FRIDAY, Oct. 25, 2024 – Many anaphylaxis protocols are incomplete and/or outdated, and there is a need for patient education regarding treatment of anaphylaxis, according to two studies presented at...
Epinephrine: Tips to the 'EpiPen' Ingredient and How It Treats Anaphylaxis
TUESDAY, Oct. 8, 2024 --- The recent approval of a new epinephrine nasal spray, Neffy, gives patients a powerful new way to keep life-threatening allergic reactions at bay. But that doesn't mean...
Monthly News Roundup - August 2024
FDA Clears Pfizer and Moderna 2024-2025 COVID-19 mRNA Vaccines On August 22, the FDA approved the latest COVID-19 mRNA monovalent vaccines from Moderna (Spikevax) and Pfizer / BioNTech (Comirnaty) ...
FDA Approves neffy (epinephrine nasal spray) Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
SAN DIEGO, Aug. 09, 2024 (GLOBE NEWSWIRE) – ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect patients...
Further information
Related condition support groups
Anaphylaxis, Allergic Reactions